Davide Leone & Partners Investment Co Ltd. Buys The Medicines Co, Allergan PLC, Tiffany, Sells Altaba Inc, Celgene Corp, Sprint Corp

• New Purchases: MDCO, AGN, TIF, HPQ, QGEN,
• Added Positions: VRTX,
• Reduced Positions: BB,
• Sold Out: AABA, CELG, S, BIIB,

For the details of Davide Leone & Partners Investment Co Ltd.'s stock buys and sells, go to https://www.gurufocus.com/guru/davide+leone+%26+partners+investment+co+ltd./current-portfolio/portfolio

1. The Medicines Co (MDCO) - 1,146,192 shares, 12.96% of the total portfolio. New Position
2. Allergan PLC (AGN) - 506,100 shares, 12.88% of the total portfolio. New Position
3. AT&T Inc (T) - 2,256,331 shares, 11.74% of the total portfolio.
4. The Medicines Co (MDCO) - 1,000,000 shares, 11.31% of the total portfolio.
5. Tiffany & Co (TIF) - 571,312 shares, 10.16% of the total portfolio. New Position

Davide Leone & Partners Investment Co Ltd. initiated holding in The Medicines Co. The purchase prices were between $49.68 and $84.94, with an estimated average price of $67.5. The stock is now traded at around $84.90. The impact to a portfolio due to this purchase was 12.96%. The holding were 1,146,192 shares as of .

Davide Leone & Partners Investment Co Ltd. initiated holding in Allergan PLC. The purchase prices were between $165.4 and $191.58, with an estimated average price of $180.86. The stock is now traded at around $198.32. The impact to a portfolio due to this purchase was 12.88%. The holding were 506,100 shares as of .

Davide Leone & Partners Investment Co Ltd. initiated holding in Tiffany & Co. The purchase prices were between $86.63 and $133.8, with an estimated average price of $119.09. The stock is now traded at around $134.27. The impact to a portfolio due to this purchase was 10.16%. The holding were 571,312 shares as of .

Davide Leone & Partners Investment Co Ltd. initiated holding in HP Inc. The purchase prices were between $16.03 and $20.69, with an estimated average price of $18.99. The stock is now traded at around $22.37. The impact to a portfolio due to this purchase was 5.47%. The holding were 2,000,000 shares as of .

Davide Leone & Partners Investment Co Ltd. initiated holding in Qiagen NV. The purchase prices were between $25.41 and $43.1, with an estimated average price of $35.32. The stock is now traded at around $37.14. The impact to a portfolio due to this purchase was 4.54%. The holding were 1,010,107 shares as of .

Davide Leone & Partners Investment Co Ltd. added to a holding in Vertex Pharmaceuticals Inc by 62.44%. The purchase prices were between $166.71 and $223.91, with an estimated average price of $203.47. The stock is now traded at around $243.82. The impact to a portfolio due to this purchase was 1.39%. The holding were 124,358 shares as of .

Davide Leone & Partners Investment Co Ltd. sold out a holding in Altaba Inc. The sale prices were between $19.63 and $19.63, with an estimated average price of $19.63.

Davide Leone & Partners Investment Co Ltd. sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.

Davide Leone & Partners Investment Co Ltd. sold out a holding in Sprint Corp. The sale prices were between $5.19 and $6.48, with an estimated average price of $5.85.

Davide Leone & Partners Investment Co Ltd. sold out a holding in Biogen Inc. The sale prices were between $220.06 and $304.07, with an estimated average price of $279.04.